Saving Minds
446 FOLLOWERS
Dr. Elliot Goldstein and Shanti Skiffington discuss the future of medicine for Alzheimer's and Parkinson's diseases with the world's leading researchers.
Saving Minds
3y ago
This episode is a recording of the White Paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee, read by Shanti Skiffington ..read more
Saving Minds
3y ago
This week Shanti and Eliot talk to Dr. Scott Napper, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, about the future of an Alzheimer’s Vaccine ..read more
Saving Minds
3y ago
On today's episode, Shanti and Eliot talk to Dr. Neil Cashman about a vaccine for Alzheimer’s disease and how that fits into the detection, treatment, and prevention of the disease ..read more
Saving Minds
3y ago
Shanti and Eliot talk to Dr. Josè Luis Molinuevo of the BarcelonaBeta Brain Research Center about his experience at AAIC, and the presentation he gave on biomarkers ..read more
Saving Minds
3y ago
This week, Shanti and Eliot talk to founder and CEO of Unlearn, Charles Fisher. They discuss how artificial intelligence can effect Alzheimer's drug research ..read more
Saving Minds
3y ago
Episode Notes
Shanti and Elliot talk to Dr. James Kupiec about a diagnostics test for Alzheimer's disease ..read more
Saving Minds
3y ago
Episode Notes
Shanti and Elliot discuss recent developments in antibody testing for Covid-19 ..read more
Saving Minds
3y ago
Elliot and Shanti talk to Johanne Kaplan about a new way to attack ALS and other protein misfolding diseases ..read more
Saving Minds
3y ago
This week Shanti and Elliot discuss Intrabodies with Dr. Johanne Kaplan ..read more
Saving Minds
3y ago
This episode is a recording of the White Paper: Perspective on Aducanumab’s Nov. 6 Advisory Committee, read by Shanti Skiffington ..read more